<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39345340</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2772-6533</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Dialogues in health</Title><ISOAbbreviation>Dialogues Health</ISOAbbreviation></Journal><ArticleTitle>Genomic analysis of the SARS-CoV-2 variants circulated in the Philippines, 2020-2024.</ArticleTitle><Pagination><StartPage>100193</StartPage><MedlinePgn>100193</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100193</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.dialog.2024.100193</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Genomic sequencing has been an invaluable tool to determine the evolution of SARS-CoV-2. In the present study, we provided a comprehensive description of the SARS-CoV-2 variants circulated in the Philippines.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The dataset from the human COVID-19 infections was acquired by downloading the sequences and their associated metadata spanning from March 2020 to April 2024. Then, we executed several filtering criteria to acquire the final dataset for the Philippine samples and performed spatial distribution analysis and phylogenetic tree construction of the reported SARS-CoV-2 sequences.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 16,679,203 SARS-CoV sequences were obtained, of which 17,393 (0.10 %) were sampled in the Philippines. Western Visayas reported the highest SARS-CoV-2 sequences (21.33 %), while the Bangsamoro Autonomous Region in Muslim Mindanao reported the least (0.48 %). The phylogenetic tree revealed the evolution of the detected SARS-CoV-2 variants circulating in the Philippines with 19 A as the first reported case (based on the GISAID submission), and 24 A (JN.1) as the currently circulating variant. Omicron variants have dominated the Philippines with 21 L (Omicron, BA.2) having 5102 cases (29.33 %), followed by 22B (BA.5) having 2184 cases (12.57 %). Using Pearson's Chi-square test of independence, we showed that there is a significant association between the age-groups and gender with the detection years.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Altogether, this analysis showed the updated epidemiological trends of the reported SARS-CoV-2 variants in the Philippines. This increases the importance of conducting surveillance on viral infectious diseases such as COVID-19 to provide the scope and trajectory of viral spread in a country.</AbstractText><CopyrightInformation>© 2024 The Authors. Published by Elsevier Inc. CC BY-NC-ND 4.0.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dimaano</LastName><ForeName>Arnie</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, College of Science, The University of Santo Tomas, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carreon</LastName><ForeName>Kiana Dominique</ForeName><Initials>KD</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, College of Science, The University of Santo Tomas, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camaya</LastName><ForeName>Giselle Sophia</ForeName><Initials>GS</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, College of Science, The University of Santo Tomas, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rondolo</LastName><ForeName>Irvin</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biology, School of Science and Engineering, Ateneo de Manila University, Philippines.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tolentino</LastName><ForeName>Jarel Elgin</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dialogues Health</MedlineTA><NlmUniqueID>9918506184906676</NlmUniqueID><ISSNLinking>2772-6533</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Philippines</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 variants</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39345340</ArticleId><ArticleId IdType="pmc">PMC11437956</ArticleId><ArticleId IdType="doi">10.1016/j.dialog.2024.100193</ArticleId><ArticleId IdType="pii">S2772-6533(24)00029-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kesheh M.M., Hosseini P., Soltani S., Zandi M. An overview on the seven pathogenic human coronaviruses. Rev Med Virol. 2022 Mar;32(2) doi: 10.1002/rmv.2282. Epub 2021 Aug 2. PMID: 34339073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2282</ArticleId><ArticleId IdType="pubmed">34339073</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization WHO COVID-19 dashboard. 2024. https://data.who.int/dashboards/covid19/cases [accessed 5 May 2024]</Citation></Reference><Reference><Citation>Tusabe F., Tahir I.M., Akpa C.I., Mtaki V., Baryamujura J., Kamau B., et al. Lessons learned from the Ebola virus disease and COVID-19 preparedness to respond to the human Monkeypox virus outbreak in low- and middle-income countries. Infect Drug Resist. 2022;28(15):6279–6286. doi: 10.2147/IDR.S384348. (PMID: 36329989; PMCID: PMC9624151)</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S384348</ArticleId><ArticleId IdType="pmc">PMC9624151</ArticleId><ArticleId IdType="pubmed">36329989</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangavarapu K., Latif A.A., Mullen J.L., Alkuzweny M., Hufbauer E., Tsueng G., et al. Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations. Nat Methods. 2023;20(4):512–522. doi: 10.1038/s41592-023-01769-3. (Epub 2023 Feb 23. PMID: 36823332; PMCID: PMC10399614)</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-023-01769-3</ArticleId><ArticleId IdType="pmc">PMC10399614</ArticleId><ArticleId IdType="pubmed">36823332</ArticleId></ArticleIdList></Reference><Reference><Citation>Outbreak.info BA.2.86 Lineage Report. 2024. https://outbreak.info/situation-reports?xmin=2023-11-11&amp;xmax=2024-05-11&amp;pango=BA.2.86 [accessed 9 May 2024]</Citation></Reference><Reference><Citation>Lambrou A.S., South E., Ballou E.S., Paden C.R., Fuller J.A., Bart S.M., et al. Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86 - Worldwide, July-October 2023. MMWR Morb Mortal Wkly Rep. 2023;72(43):1162–1167. doi: 10.15585/mmwr.mm7243a2. [PMID: 37883327; PMCID: PMC10602619]</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7243a2</ArticleId><ArticleId IdType="pmc">PMC10602619</ArticleId><ArticleId IdType="pubmed">37883327</ArticleId></ArticleIdList></Reference><Reference><Citation>Saravanan K.A., Panigrahi M., Kumar H., Rajawat D., Nayak S.S., Bhushan B., et al. Role of genomics in combating COVID-19 pandemic. Gene. 2022;20(823) doi: 10.1016/j.gene.2022.146387. [Epub 2022 Mar 4. PMID: 35248659; PMCID: PMC8894692]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2022.146387</ArticleId><ArticleId IdType="pmc">PMC8894692</ArticleId><ArticleId IdType="pubmed">35248659</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosta S., Moreno K., Schuab G., Fonseca V., Segovia F.M.C., Kashima S., et al. Global SARS-CoV-2 genomic surveillance: What we have learned (so far) Infect Genet Evol. 2023;108:105405. doi: 10.1016/j.meegid.2023.105405. (Epub 2023 Jan 18. PMID: 36681102; PMCID: PMC9847326)</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2023.105405</ArticleId><ArticleId IdType="pmc">PMC9847326</ArticleId><ArticleId IdType="pubmed">36681102</ArticleId></ArticleIdList></Reference><Reference><Citation>Philstar Philippines detects 18 cases of new COVID-19 variant JN.1. 2023. https://www.philstar.com/headlines/2023/12/24/2321179/philippines-detects-18-cases-new-covid-19-variant-jn1 [accessed 9 May 2024]</Citation></Reference><Reference><Citation>Khare S., Gurry C., Freitas L., Schultz M.B., Bach G., Diallo A., Akite N., Ho J., Lee R.T., Yeo W., Curation Team G.C., Maurer-Stroh S. GISAID’s Role in Pandemic Response. China CDC Wkly. 2021;3(49):1049–1051. doi: 10.46234/ccdcw2021.255. PMID: 34934514; PMCID: PMC8668406.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.255</ArticleId><ArticleId IdType="pmc">PMC8668406</ArticleId><ArticleId IdType="pubmed">34934514</ArticleId></ArticleIdList></Reference><Reference><Citation>Aksamentov I., Roemer C., Hodcroft E.B., Neher R.A. Nextclade: clade assignment, mutation calling and quality control for viral genomes. J Open Source Software. 2021;6(67):3773. doi: 10.21105/joss.03773.</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.03773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahle D., Wickham H. ggmap: Spatial Visualization with ggplot2. R Journal. 2024;5(1):144–161.</Citation></Reference><Reference><Citation>Li H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34(18):3094–3100. doi: 10.1093/bioinformatics/bty191. PMID: 29750242; PMCID: PMC6137996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty191</ArticleId><ArticleId IdType="pmc">PMC6137996</ArticleId><ArticleId IdType="pubmed">29750242</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson B. Gofasta: command-line utilities for genomic epidemiology research. Bioinformatics. 2022;38(16):4033–4035. doi: 10.1093/bioinformatics/btac424. (PMID: 35789376; PMCID: PMC9364388)</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btac424</ArticleId><ArticleId IdType="pmc">PMC9364388</ArticleId><ArticleId IdType="pubmed">35789376</ArticleId></ArticleIdList></Reference><Reference><Citation>Capella-Gutiérrez S., Silla-Martínez J.M., Gabaldón T. trimAl: a tool for automated alignment trimming in large-scale phylogenetic analyses. Bioinformatics. 2009;25(15):1972–1973. doi: 10.1093/bioinformatics/btp348. [Epub 2009 Jun 8. PMID: 19505945; PMCID: PMC2712344]</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp348</ArticleId><ArticleId IdType="pmc">PMC2712344</ArticleId><ArticleId IdType="pubmed">19505945</ArticleId></ArticleIdList></Reference><Reference><Citation>Minh B.Q., Schmidt H.A., Chernomor O., Schrempf D., Woodhams M.D., von Haeseler A., et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol. 2020;37(5):1530–1534. doi: 10.1093/molbev/msaa015. Erratum in:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msaa015</ArticleId><ArticleId IdType="pmc">PMC7182206</ArticleId><ArticleId IdType="pubmed">32011700</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G. Using ggtree to visualize data on tree-like structures. Curr Protoc Bioinformatics. 2020;69(1) doi: 10.1002/cpbi.96. [PMID: 32162851]</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cpbi.96</ArticleId><ArticleId IdType="pubmed">32162851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W., Kim H., Choi H.M., Heo S., Fong K.C., Yang J., et al. Urban environments and COVID-19 in three eastern states of the United States. Sci Total Environ. 2021;20(779) doi: 10.1016/j.scitotenv.2021.146334. [Epub 2021 Mar 12. PMID: 33744577; PMCID: PMC7952127]</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scitotenv.2021.146334</ArticleId><ArticleId IdType="pmc">PMC7952127</ArticleId><ArticleId IdType="pubmed">33744577</ArticleId></ArticleIdList></Reference><Reference><Citation>Souch J.M., Cossman J.S. A commentary on rural-urban disparities in COVID-19 testing rates per 100,000 and risk factors. J Rural Health. 2021;37(1):188–190. doi: 10.1111/jrh.12450. [Epub 2020 Jun 1. PMID: 32282964; PMCID: PMC7262182]</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jrh.12450</ArticleId><ArticleId IdType="pmc">PMC7262182</ArticleId><ArticleId IdType="pubmed">32282964</ArticleId></ArticleIdList></Reference><Reference><Citation>Gili R., Burioni R. SARS-CoV-2 before and after omicron: two different viruses and two different diseases? J Transl Med. 2023;21(1):251. doi: 10.1186/s12967-023-04095-6. PMID: 37038133; PMCID: PMC10088248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-023-04095-6</ArticleId><ArticleId IdType="pmc">PMC10088248</ArticleId><ArticleId IdType="pubmed">37038133</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar A., Omar S., Alshareef A., Fanous K., Sarker S., Alroobi H., et al. The relative prevalence of the omicron variant within SARS-CoV-2 infected cohorts in different countries: a systematic review. Hum Vaccin Immunother. 2023;19(1):2212568. doi: 10.1080/21645515.2023.2212568. (PMID: 37254497; PMCID: PMC10234134)</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2023.2212568</ArticleId><ArticleId IdType="pmc">PMC10234134</ArticleId><ArticleId IdType="pubmed">37254497</ArticleId></ArticleIdList></Reference><Reference><Citation>Outbreak.info KP.2 Lineage Report. 2024. https://outbreak.info/situation-reports?xmin=2023-11-11&amp;xmax=2024-05-11&amp;pango=KP.2 [accessed 9 May 2024]</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>